Press Releases
Cardiome to Release Third Quarter Results
PRNewswire | 1 day 1 hour 41 minutes ago
NASDAQ: CRME TSX: COM... (more)
Hospira to Present at Piper Jaffray 21st Annual Health Care Conference Dec. 2
PRNewswire | 1 day 1 hour 42 minutes ago
... (more)
Microbix Biosystems Re-files Annual Results With OSC
PRNewswire | 1 day 3 hours 41 minutes ago
TORONTO, Nov. 6 /PRNewswire-FirstCall/ - Microbix Biosystems Inc. (the "Company") announces today that it has re-filed the Form 52-109F1 Certification of Annual Filings of William Gastle, the Chief Executive Officer and James Long, the Chief Financial Officer (the "Officer's Certificates") dated January 12, 2009 in connection with the annual audited financial statements for the year ended September 30, 2008.... (more)
Watson to Present at Credit Suisse Healthcare Conference
PRNewswire | 1 day 3 hours 41 minutes ago
... (more)
DUSA Pharmaceuticals to Present at the Merriman Curhan Ford Investor Summit 2009
PRNewswire | 1 day 4 hours 10 minutes ago
... (more)
Stull, Stull & Brody Announces Investigation on Behalf of Shareholders of Trimeris, Inc.
Business Wire | 1 day 4 hours 12 minutes ago
Attorney Advertising. Notice is hereby given that Stull, Stull & Brody has commenced an investigation on behalf of shareholders of Trimeris, Inc. (“Trimeris” or the “Company”) (Nasdaq: TRMS) for possible breaches of fiduciary duty and other violations of state law in connection with an agreement by the Trimeris Board of Directors to sell all of the Company’s outstanding shares of common stock at a price of $3.60 per share to Arigene Co., Ltd. (“Arigene”).... (more)
Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution
PRNewswire | 1 day 9 hours 42 minutes ago
... (more)
Stellar Pharmaceuticals' Q3-2009 Financial Results Marked by Strong Growth and Continued Profitability
MarketWire | 1 day 9 hours 42 minutes ago
LONDON, ONTARIO -- (Marketwire) -- 11/06/09 -- Stellar Pharmaceuticals Inc. ("Stellar" or "the Company") (OTCBB: SLXCF), a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets, today announced its financial results for the third quarter ended September 30, 2009. In this press release, unless otherwise indicated, all dollar amounts are expressed in Canadian dollars and have been rounded to nearest hundred. ... (more)
Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting
PRNewswire | 1 day 10 hours 11 minutes ago
... (more)
Helix BioMedix Reports Third Quarter 2009 Financial Results
Business Wire | 1 day 10 hours 11 minutes ago
Helix BioMedix, Inc. (OTCBB: HXBM), a developer of bioactive peptides, today announced financial results for the third quarter ended September 30, 2009.... (more)
Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results
PRNewswire | 1 day 11 hours 41 minutes ago
SAN DIEGO, Nov. 6 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. ... (more)
GTC Biotherapeutics Reports Third Quarter 2009 Financial Results
Business Wire | 1 day 11 hours 41 minutes ago
GTC Biotherapeutics, Inc.’s ("GTC", NASDAQ: GTCB) total net loss for the third quarter ended September 27, 2009 was $5.1 million, or $0.48 per share, compared with $6.1 million, or $0.59 per share, in the third quarter of 2008. The total net loss for the first nine months of 2009 was $26.2 million, or $2.51 per share, compared to $16.5 million, or $1.71 per share, for the first nine months of 2008.... (more)
108 Press Releases |
RSS Feed
Sign up for BIO SmartBrief
Latest Blog Postsview more
Ants are friendly to some trees, but not others
Science Blog
AIBS publishes Darwin articles open access
Science Blog
Higher carotid arterial stenting rates associated with poorer clinical outcomes
Science Blog
AIBS publishes Darwin articles open access
Science Blog
Companies in the news
- Amylin Pharmaceuticals Inc.
- Cipla Ltd.
- GlaxoSmithKline plc
- Human Genome Sciences
- Huntingdon
- Johnson & Johnson
- Lilly
- Merck & Co.
- Novartis
- Novartis AG
- Nutra Pharma Corporation
- Pfizer
- PharmaNet Development Group, Inc.
- Roche
- Schering-Plough
